Anju’s Feasibility Flex in TA Scan Wins Best of Show at SCOPE Summit Europe

FORT LAUDERDALE, Fla., Oct. 31, 2024 /PRNewswire/ — Anju Software recently introduced Feasibility Flex, the newest feature in the flagship product, TA Scan, designed to transform clinical trial feasibility assessments. This powerful tool addresses the rising complexities of trial design and execution, providing unmatched flexibility and precision to enhance trial planning. Feasibility Flex recently won Best of Show at SCOPE Summit Europe for its innovative impact on life sciences. The award, chosen by attendees, celebrates exhibitors advancing clinical research with meaningful solutions.

Feasibility Flex allows clinical teams to input and adjust key trial parameters, ensuring more accurate enrollment projections and informed site selection. This adaptability is critical in modern trials, where fluctuating regulations, global patient recruitment challenges, and intricate protocols add layers of complexity and unpredictability. The feature harnesses TA Scan’s high quality clinical data alongside user insights, such as signature site lists and country-level start-up timelines, to deliver precision insights for strategic and operational planning.

Key capabilities of Feasibility Flex include:

  • Leveraging Data for Precision Enrollment: Build enrollment scenarios with high-quality data, enhanced by user insights, for accurate and tailored enrollment projections.
  • Dynamic Site and Country Intelligence: Fine-tune projections and site recommendations by adjusting parameters in real time. Visualize projected country-level timelines, with options to customize regulatory delay.
  • Predictability in Trial Planning: Gain comprehensive insights for informed trial planning, resulting in more efficient and predictable trials.

Feasibility Flex empowers teams to make data-driven decisions faster and with greater confidence. In an industry where only 10-12% of drugs reach the market, this feature provides an essential edge, helping organizations avoid delays, manage costs, and reduce inefficiencies.

Discover how TA Scan can transform your trial planning. Visit our website or contact our team at info@anjusoftware.com to schedule a demo today!

About Anju Software
Anju is a customer-first organization delivering adaptable life science solutions for clinical researchmedical affairs, and data science. TrialMasterIRMS MAX, and TA Scan, the company’s flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. With a team of industry experts and a diverse suite of versatile products, Anju empowers clients to drive innovation, efficiency, and compliance. Anju is a portfolio company of Valsoft serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.

Media Contact
John F. Kouten
JFK Communications, Inc.
+1 609.241.7352
jfkouten@jfkhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/anjus-feasibility-flex-in-ta-scan-wins-best-of-show-at-scope-summit-europe-302292973.html

SOURCE Anju Software

Staff

Recent Posts

Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy

Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF)…

52 minutes ago

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

3 hours ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

3 hours ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

3 hours ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

3 hours ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

3 hours ago